Nawe, Diaser .
HRN: 22-11-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/27/2022
10/31/2022
PO
5 Ml
Q12
Intestinal Parasitism
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes